DHR vs UPS: Which Is the Better Buy?

Side-by-side comparison of Danaher Corporation and United Parcel Service, Inc. β€” fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-06-20.
Danaher Corporation Β· Healthcare
$177.17
+8.9% upside to fair value
Grade B High Quality
VS
United Parcel Service, Inc. Β· Industrials
$105.00
+12.9% upside to fair value
Grade B
QuantHub Verdict
UPS has more upside to fair value (+12.9%). UPS trades at a lower forward P/E (17.0x). These are model outputs β€” not personalized investment advice. See all research β†’
Valuation & Fundamentals
Metric DHR UPS
Current Price $177.17 $105.00
Fair Value Estimate $192.90 $118.53
Upside to Fair Value +8.9% +12.9%
Market Cap $125.4B $89.2B
Forward P/E 34.1x 17.0x
EV / EBITDA 20.8x 9.6x
Price / Sales 5.1x 1.0x
Price / FCF 23.7x 19.8x
Revenue Growth YoY +3.7% -1.6%
Gross Margin 60.7% 17.8%
Operating Margin 21.0% 8.5%
Return on Equity 7.1% 33.0%
Dividend Yield 0% 0%
FCF Yield 4.22% 5.06%
Analyst Consensus Strong Buy Buy
Investment Thesis
DHR β€” Danaher Corporation
Danaher Corporation operates in the healthcare sector, specializing in medical diagnostics and research tools through three balanced platforms: Biotechnology, Life Sciences, and Diagnostics. The company benefits from a durable competitive moat supported by the Danaher Business System, disciplined capital allocation, and a platform-centric organizational structure. Despite modest revenue growth of…
UPS β€” United Parcel Service, Inc.
United Parcel Service, Inc. operates as a global integrated freight and logistics company with a strong presence in U.S. domestic package delivery, international package services, and supply chain solutions. The company benefits from a durable competitive moat supported by its extensive network capabilities, premium service positioning, and strategic focus on higher-margin segments such as health…
Accumulation Zones
Metric DHR UPS
Zone Low $144.68 $88.90
Zone High $163.97 $100.75
In Buy Zone? No No
← DHR Research    UPS Research β†’    All Research